| Yesim Yilmaz Demirdag, MD | |
|
821 Health Sciences Rd Medical Sciences I C-240, Irvine, CA 92697-9214 | |
| (949) 824-5818 | |
| Not Available |
| Full Name | Yesim Yilmaz Demirdag |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 34 Years |
| Location | 821 Health Sciences Rd Medical Sciences I C-240, Irvine, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134330921 | NPI | - | NPPES |
| 07225 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | C166841 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of California Irvine Medical Center | Orange, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uc Regents | 7416869516 | 205 |
News Archive
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
According to the most comprehensive survey of people affected by Hurricane Katrina, results of which are being presented today to the U.S. Senate Committee on Homeland Security and Government Affairs Ad Hoc Subcommittee on Disaster Recovery, the percentage of pre-hurricane residents of the affected areas in Alabama, Louisiana, and Mississippi who have mental disorders has increased significantly compared to the situation five to eight months after the hurricane.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
Electronic cigarette use continues to rise, and current data regarding use of e-cigarettes among college students are needed.
› Verified 3 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760430847 PECOS PAC ID: 7416869516 Enrollment ID: O20031118000906 |
News Archive
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
According to the most comprehensive survey of people affected by Hurricane Katrina, results of which are being presented today to the U.S. Senate Committee on Homeland Security and Government Affairs Ad Hoc Subcommittee on Disaster Recovery, the percentage of pre-hurricane residents of the affected areas in Alabama, Louisiana, and Mississippi who have mental disorders has increased significantly compared to the situation five to eight months after the hurricane.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
Electronic cigarette use continues to rise, and current data regarding use of e-cigarettes among college students are needed.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yesim Yilmaz Demirdag, MD Po Box 9214, West Virginia University, Morgantown, WV 26506-9214 Ph: (304) 293-1201 | Yesim Yilmaz Demirdag, MD 821 Health Sciences Rd Medical Sciences I C-240, Irvine, CA 92697-9214 Ph: (949) 824-5818 |
News Archive
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
According to the most comprehensive survey of people affected by Hurricane Katrina, results of which are being presented today to the U.S. Senate Committee on Homeland Security and Government Affairs Ad Hoc Subcommittee on Disaster Recovery, the percentage of pre-hurricane residents of the affected areas in Alabama, Louisiana, and Mississippi who have mental disorders has increased significantly compared to the situation five to eight months after the hurricane.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
Electronic cigarette use continues to rise, and current data regarding use of e-cigarettes among college students are needed.
› Verified 3 days ago
Dr. Francis Yu, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 14150 Culver Dr, Ste 302, Irvine, CA 92604 Phone: 949-551-1001 Fax: 949-551-1019 | |
Dr. Rhonda Jan Myers, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4902 Irvine Center Dr, Suite 108, Irvine, CA 92604 Phone: 949-552-3121 Fax: 949-552-3723 | |
Dr. Ankmalika Abha Gupta, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1 Medical Plaza Drive, Irvine, CA 92697 Phone: 949-824-8600 | |
Dr. Soo Hyun Choi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 6 Willard, Allergy Clinic, Irvine, CA 92604 Phone: 888-988-2800 |